These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23566246)

  • 1. The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.
    Bielecka-Dabrowa A; Mikhailidis DP; Rizzo M; von Haehling S; Rysz J; Banach M
    Lipids Health Dis; 2013 Apr; 12():47. PubMed ID: 23566246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy.
    Bielecka-Dabrowa A; Goch JH; Mikhailidis DP; Rysz J; Maciejewski M; Banach M
    Med Sci Monit; 2009 Dec; 15(12):MS12-23. PubMed ID: 19946241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.
    Bielecka-Dabrowa A; Goch JH; Rysz J; Maciejewski M; Desai R; Aronow WS; Banach M
    Lipids Health Dis; 2010 Feb; 9():21. PubMed ID: 20178563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
    Liu M; Wang F; Wang Y; Jin R
    Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure.
    Sola S; Mir MQ; Lerakis S; Tandon N; Khan BV
    J Am Coll Cardiol; 2006 Jan; 47(2):332-7. PubMed ID: 16412856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy.
    Tsutamoto T; Sakai H; Ibe K; Yamaji M; Kawahara C; Nakae I; Fujii M; Yamamoto T; Horie M
    Circ J; 2011; 75(9):2160-6. PubMed ID: 21737951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tamaki S; Tsukamoto Y; Masuda M; Okuda K; Fukunami M
    Am J Med Sci; 2006 Dec; 332(6):361-3. PubMed ID: 17170629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure.
    Stypmann J; Schubert A; Welp H; Schulte H; Assmann G; Breithardt G; Nofer JR
    Clin Cardiol; 2008 Oct; 31(10):478-81. PubMed ID: 18855352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide.
    Abulhul E; McDonald K; Martos R; Phelan D; Spiers JP; Hennessy M; Baugh J; Watson C; O'Loughlin C; Ledwidge M
    Clin Ther; 2012 Jan; 34(1):91-100. PubMed ID: 22154198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
    Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
    Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels.
    Wojnicz R; Wilczek K; Nowalany-Kozielska E; Szyguła-Jurkiewicz B; Nowak J; Poloński L; Dyrbuś K; Badziński A; Mercik G; Zembala M; Wodniecki J; Rozek MM
    Am J Cardiol; 2006 Mar; 97(6):899-904. PubMed ID: 16516598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study.
    Li Q; Deng SB; Xia S; Du JL; She Q
    Med Clin (Barc); 2013 Jun; 140(12):532-6. PubMed ID: 23177313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
    Tatli E; Kurum T
    Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure.
    Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Pitsavos C; Vlachopoulos C; Panagiotakos D; Stefanadis C
    Atherosclerosis; 2005 Feb; 178(2):359-63. PubMed ID: 15694946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
    Athyros VG; Elisaf M; Papageorgiou AA; Symeonidis AN; Pehlivanidis AN; Bouloukos VI; Milionis HJ; Mikhailidis DP;
    Am J Kidney Dis; 2004 Apr; 43(4):589-99. PubMed ID: 15042535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a loading dose of atorvastatin before percutaneous coronary intervention prevents inflammation and reduces myocardial injury in STEMI patients: a randomized clinical study.
    Liu HL; Yang Y; Yang SL; Luo JP; Li H; Jing LM; Shen ZQ
    Clin Ther; 2013 Mar; 35(3):261-72. PubMed ID: 23410871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection function.
    Chotenimitkhun R; D'Agostino R; Lawrence JA; Hamilton CA; Jordan JH; Vasu S; Lash TL; Yeboah J; Herrington DM; Hundley WG
    Can J Cardiol; 2015 Mar; 31(3):302-7. PubMed ID: 25662284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
    Stumpf C; Petzi S; Seybold K; Wasmeier G; Arnold M; Raaz D; Yilmaz A; Daniel WG; Garlichs CD
    Clin Sci (Lond); 2009 Jan; 116(1):45-52. PubMed ID: 18459941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Atorvastatin on Cardiac Performance for Dilated Cardiomyopathy: A Meta-analysis of Randomized Controlled Studies.
    Fu L; Shang X; Zhang X
    Heart Surg Forum; 2020 May; 23(3):E329-E334. PubMed ID: 32524984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.